BRUCE DATA PORTAL
About Us
Our Research
We are committed to advancing the understanding and treatment of primary brain tumors—some of the most lethal cancers affecting both adults and children. Despite decades of research, effective therapies remain elusive, and survival rates have not significantly improved. To address this challenge, we have assembled one of the largest and most diverse glioma tissue cohorts. This cohort includes adult and pediatric patients, covering treatment-naive, post-immunotherapy, and recurrent cases. Utilizing cutting-edge high-dimensional imaging technologies, we have created a comprehensive spatial multi-omic atlas of gliomas, focusing on better understanding the tumor microenvironment (TME) and unraveling the mechanisms of treatment resistance.
Our Team
The driving force behind our research and operations
Mike Angelo, MD PhD
Principle Investigator, Associate Professor, Stanford University
Sean Bendall, PhD
Principle Investigator, Associate Professor, Stanford University
Hadeesha Piyadasa, PhD
Postdoctoral Fellow, Stanford University
Benjamin Oberlton
PhD Graduate Student, Stanford University
Our Collaborators
The scientists who shared samples and drove science forward
Crystal Mackall
Professor, Stanford University
Robert M. Prins
Professor, Neurosurgery and Pharmacology, David Geffen School of Medicine at UCLA
Hideho Okada
Professor, University of California, San Francisco
Christine Brown
Professor, City of Hope
Kristina Cole
Associate Professor, Children's Hospital of Philadelphia
Derek Oldridge
Assistant Professor, Children's Hospital of Philadelphia
Joanna J. Phillips
Professor, Brain Tumor Center, UCSF
PICI
The Parker Institute provided funding and guidance
EnJun Yang
Research Director, PICI
Mike Travers
Consultant, Hyperphor
Get Involved
There are many ways to get involved with the Parker Institute for Cancer Immunotherapy and support our mission:
